We have been one of the multisite locations of the Autism Treatment Network (ATN) since January 2008. As part of the ATN, our patients with autism spectrum disorders (ASD) are eligible to be entered into a registry designed to track co-occurring medical and psychiatric conditions and treatments. We also participate in studies through the Autism Intervention Research – Physical Health Network (AIR-P), which is funded by HRSA via the Combating Autism Act Initiative (CAAI). We are collaborating with other ATN sites on studies that involve nutrition, sleep, iron metabolism, and creatine deficiency, to name a few. We also participate in a multisite, case-cohort study of the etiology of autism, which is funded by the CDC.
The eXtraordinarY Kids Clinic has a grant to evaluate genotype-phenotype correlations in individuals with sex chromosome aneuploidy and will establish a repository of DNA for future genetic studies. We will also study the behavioral and motor effects of testosterone replacement therapy in adolescent males with XXY and XXYY syndromes.
We are a member of the National Fragile X Foundation’s Fragile X Clinical and Research Consortium, which was recently funded by the CDC to develop a registry of subjects with Fragile X for the purpose of tracking medical and behavioral features and to facilitate future clinical trials.
We also have funding through the Colorado Clinical Translational Science Institute, funded by NIH, to evaluate barriers social-emotional screening in a Latino population.
Drs. Friedman, Reynolds, and Tartaglia are also members of the Intellectual and Developmental Disabilities Research Center (IDDRC) faculty.